Trial Profile
Measurement-based Care for Depression in Resource-Poor Settings
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Fluoxetine (Primary)
- Indications Depression
- Focus Therapeutic Use
- 29 Nov 2016 Status changed from active, no longer recruiting to completed.
- 30 Sep 2016 New trial record